COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.
-
Page/Page column 138
(2019/07/19)
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
-
Paragraph 0657-0658
(2019/07/10)
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.
-
Page/Page column 135
(2019/07/19)
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
The present invention is directed to morpholine carboxamide compounds which are antagonists of prokineticin receptors, in particular antagonists of prokineticin 2 receptors, and which are useful in the treatment or prevention of neurological and psychiatr
-
Page/Page column 36
(2008/06/13)
Studies on the neuroleptic benzamides. I. - Synthesis and antidopaminergic properties of new pyrimidine derivatives
-
Dostert,Imbert,Ancher,et al.
p. 437 - 444
(2007/10/02)
More Articles about upstream products of 84332-00-3